Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

January 7, 2021

Study Completion Date

February 5, 2021

Conditions
Colonoscopy
Interventions
DRUG

Bowel Prep

Orally ingested liquid bowel preparation

Trial Locations (34)

11023

302 Research Site 37, Great Neck

11235

302 Research Site 39, Brooklyn

21742

302 Research Site 16, Hagerstown

22031

302 Research Site 4, Fairfax

22911

302 Research Site 6, Charlottesville

27262

302 Research Site 25, High Point

27612

302 Research Site 1, Raleigh

28403

302 Research Site 13, Wilmington

28801

302 Research Site 8, Asheville

32003

302 Research Site 17, Fleming Island

32256

302 Research Site 14, Jacksonville

33134

302 Research Site 28, Miami

33155

302 Research Site 29, Miami

302 Research Site 30, Miami

34452

302 Research Site 3, Inverness

34684

302 Research Site 38, Palm Harbor

37660

302 Research Site 33, Kingsport

38305

302 Research Site 23, Jackson

45219

302 Research Site 18, Cincinnati

60453

302 Research Site 5, Oak Lawn

70471

302 Research Site 26, Mandeville

70809

302 Research Site 34, Baton Rouge

71201

302 Research Site 36, Monroe

72117

302 Research Site 11, North Little Rock

72211

302 Research Site 10, Little Rock

76092

302 Research Site 35, Southlake

77058

302 Research Site 21, Houston

77598

302 Research Site 27, Webster

78613

302 Research Site 32, Cedar Park

85712

302 Research Site 2, Tucson

90036

302 Research Site 31, Los Angeles

91910

302 Research Site 9, Chula Vista

98004

302 Research Site 7, Bellevue

06010

302 Research Site 22, Bristol

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY